Rapid diagnosis and prognosis of de novo acute myeloid leukemia by serum metabonomic analysis

Journal of Proteome Research

Volumn 12, Issue 10, 2013, Pages 4393-4401

  Wang, Yihuang ^a,d   Zhang, Limin ^b   Chen, Wen Lian ^a   Wang, Jing Han ^a   Li, Ning ^b   Li, Jun Min ^a   Mi, Jian Qing ^a   Zhang, Wei Na ^a   Li, Yang ^a   Wu, Song Fang ^a,d   Jin, Jie ^c   Wang, Yun Gui ^c   Huang, He ^c   Chen, Zhu ^a,d   Chen, Sai Juan ^a,d   Tang, Huiru ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Wuhan National Laboratory for Optoelectronics   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d Shanghai Jiao Tong University   (China)

Author keywords

acute myeloid leukemia; diagnosis; metabonomics; NMR; prognosis

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETYLCARNITINE; ALANINE; ARGININE; CHOLINE; CITRIC ACID; FATTY ACID; FORMIC ACID; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; GLYCEROPHOSPHORYLCHOLINE; GLYCINE; HIGH DENSITY LIPOPROTEIN; HISTIDINE; INOSITOL; LACTIC ACID; LEUCINE; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LYSINE; MANNOSE; PHENYLALANINE; PHOSPHORYLCHOLINE; SUCCINIMIDE; TYROSINE; UNSATURATED FATTY ACID; VALINE; VERY LOW DENSITY LIPOPROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CELL MEMBRANE; CITRIC ACID CYCLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOGENETICS; GLUCONEOGENESIS; GLYCOLYSIS; HUMAN; METABOLOMICS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN SYNTHESIS; PROTON NUCLEAR MAGNETIC RESONANCE; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; METABOLOMICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84885216874     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr400403p     Document Type: Article

References (60)

1. Jemal, A.; Bray, F.; Center, M. M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics CA-Cancer J. Clin. 2011, 61, 69-90
2. Bennett, J. M.; Catovsky, D.; Daniel, M. T.; Flandrin, G.; Galton, D. A.; Gralnick, H. R.; Sultan, C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group Br. J. Hamaetol. 1976, 33, 451-458
3. Mi, J. Q.; Li, J. M.; Shen, Z. X.; Chen, S. J.; Chen, Z. How to manage acute promyelocytic leukemia Leukemia 2012, 26, 1743-1751
4. Zou, P. Standardized diagnosis and treatment for acute myelocytic leukemia Chin. J. Pract. Intern. Med. 2007, 27, 1110-1112
5. Roboz, G. J. Novel approaches to the treatment of acute myeloid leukemia Hematol. Am. Soc. Hematol. Educ. Program 2011, 43-50
6. Vardiman, J. W.; Thiele, J.; Arber, D. A.; Brunning, R. D.; Borowitz, M. J.; Porwit, A.; Harris, N. L.; Le Beau, M. M.; Hellström-Lindberg, E.; Tefferi, A.; Bloomfield, C. D. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes Blood 2009, 114, 937-951
7. Grimwade, D.; Hills, R. K. Independent prognostic factors for AML outcome Hematol. Am. Soc. Hematol. Educ. Program 2009, 385-395
8. O'Donnell, M. R.; Abboud, C. N.; Altman, J.; Appelbaum, F. R.; Arber, D. A.; Attar, E.; Borate, U.; Coutre, S. E.; Damon, L. E.; Goorha, S.; Lancet, J.; Maness, L. J.; Marcucci, G.; Millenson, M. M.; Moore, J. O.; Ravandi, F.; Shami, P. J.; Smith, B. D.; Stone, R. M.; Strickland, S. A.; Tallman, M. S.; Wang, E. S.; Naganuma, M.; Gregory, K. M. Acute myeloid leukemia J. Natl. Compr. Cancer Network 2012, 10, 984-1021
9. Grimwade, D.; Hills, R. K.; Moorman, A. V.; Walker, H.; Chatters, S.; Goldstone, A. H.; Wheatley, K.; Harrison, C. J.; Burnett, A. K. National Cancer Research Institute Adult Leukaemia Working Group. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials Blood 2010, 116, 354-365
10. Gilliland, D. G.; Griffin, J. D. The roles of FLT3 in hematopoiesis and leukemia Blood 2002, 100, 1532-1542
11. Falini, B.; Mecucci, C.; Tiacci, E.; Alcalay, M.; Rosati, R.; Pasqualucci, L.; La Starza, R.; Diverio, D.; Colombo, E.; Santucci, A.; Bigerna, B.; Pacini, R.; Pucciarini, A.; Liso, A.; Vignetti, M.; Fazi, P.; Meani, N.; Pettirossi, V.; Saglio, G.; Mandelli, F.; Lo-Coco, F.; Pelicci, P. G.; Martelli, M. F. GIMEMA Acute Leukemia Working Party. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype N. Engl. J. Med. 2005, 352, 254-266
12. Haferlach, C.; Mecucci, C.; Schnittger, S.; Kohlmann, A.; Mancini, M.; Cuneo, A.; Testoni, N.; Rege-Cambrin, G.; Santucci, A.; Vignetti, M.; Fazi, P.; Martelli, M. P.; Haferlach, T.; Falini, B. AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features Blood 2009, 114, 3024-3032
13. Smith, M. L.; Cavenagh, J. D.; Lister, T. A.; Fitzgibbon, J. Mutation of CEBPA in familial acute myeloid leukemia N. Engl. J. Med. 2004, 351, 2403-2407
14. Foran, J. M. New prognostic markers in acute myeloid leukemia: perspective from the clinic Hematology Am Soc Hematol Educ Program 2010, 47-55
15. Nicholson, J. K.; Lindon, J. C. Systems biology: Metabonomics Nature 2008, 455, 1054-1056
16. Nicholson, J. K.; Wilson, I. D. Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism Nat. Rev. Drug Discovery 2003, 2, 668-676
17. 1H-NMR-based metabonomics Nat. Med. 2002, 8, 1439-1444
18. Xu, W.; Wu, J.; An, Y.; Xiao, C.; Hao, F.; Liu, H.; Wang, Y.; Tang, H. Streptozotocin-Induced Dynamic Metabonomic Changes in Rat Biofluids J. Proteome Res. 2012, 11, 3423-3435
19. Marchesi, J. R.; Holmes, E.; Khan, F.; Kochhar, S.; Scanlan, P.; Shanahan, F.; Wilson, I. D.; Wang, Y. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease J. Proteome Res. 2007, 6, 546-551
20. Bjerrum, J. T.; Nielsen, O. H.; Hao, F.; Tang, H.; Nicholson, J. K.; Wang, Y.; Olsen, J. Metabonomics in ulcerative colitis: diagnostics, biomarker identification, and insight into the pathophysiology J. Proteome Res. 2010, 9, 954-962
21. Cheng, L. L.; Ma, M. J.; Becerra, L.; Ptak, T.; Tracey, I.; Lackner, A.; González, R. G. Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 6408-6413
22. 1H nuclear magnetic resonance spectroscopy and principal component analysis Prog. Biochem. Biophys. 2008, 35, 1142-1153
23. Sreekumar, A.; Poisson, L. M.; Rajendiran, T. M.; Khan, A. P.; Cao, Q.; Yu, J.; Laxman, B.; Mehra, R.; Lonigro, R. J.; Li, Y.; Nyati, M. K.; Ahsan, A.; Kalyana-Sundaram, S.; Han, B.; Cao, X.; Byun, J.; Omenn, G. S.; Ghosh, D.; Pennathur, S.; Alexander, D. C.; Berger, A.; Shuster, J. R.; Wei, J. T.; Varambally, S.; Beecher, C.; Chinnaiyan, A. M. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression Nature 2009, 457, 910-914
24. 1H NMR spectroscopy in conjunction with multivariate data analysis J. Proteome Res. 2007, 6, 2605-2614
25. MacIntyre, D. A.; Jimenez, B.; Lewintre, E. J.; Martin, C. R.; Schafer, H.; Ballesteros, C. G.; Mayans, J. R.; Spraul, M.; Garcia-Conde, J.; Pineda-Lucena, A. Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups Leukemia 2010, 24, 788-797
26. 1H-NMR-based metabonomics Int. J. Cancer 2005, 113, 782-788
27. 1H NMR-based metabolomics Neoplasia 2009, 11, 269-276
28. Tiziani, S.; Lodi, A.; Khanim, F. L.; Viant, M. R.; Bunce, C. M.; Gunther, U. L. Metabolomic profiling of drug responses in acute myeloid leukaemia cell lines PLoS One 2009, 4, e4251
29. Lodi, A.; Tiziani, S.; Khanim, F. L.; Drayson, M. T.; Gunther, U. L.; Bunce, C. M.; Viant, M. R. Hypoxia triggers major metabolic changes in AML cells without altering indomethacin-induced TCA cycle deregulation ACS Chem. Biol. 2011, 6, 169-175
30. Shen, Y.; Zhu, Y. M.; Fan, X.; Shi, J. Y.; Wang, Q. R.; Yan, X. J.; Gu, Z. H.; Wang, Y. Y.; Chen, B.; Jiang, C. L.; Yan, H.; Chen, F. F.; Chen, H. M.; Chen, Z.; Jin, J.; Chen, S. J. Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia Blood 2011, 118, 5593-5603
31. Zhang, X.; Wang, Y.; Hao, F.; Zhou, X.; Han, X.; Tang, H.; Ji, L. Human serum metabonomic analysis reveals progression axes for glucose intolerance and insulin resistance statuses J. Proteome Res. 2009, 8, 5188-5195
32. Dai, H.; Xiao, C.; Liu, H.; Tang, H. Combined NMR and LC-MS analysis reveals the metabonomic changes in Salvia miltiorrhiza Bunge induced by water depletion J. Proteome Res. 2010, 9, 1460-1475
33. Dai, H.; Xiao, C.; Liu, H.; Hao, F.; Tang, H. Combined NMR and LC-DAD-MS analysis reveals comprehensive metabonomic variations for three phenotypic cultivars of Salvia Miltiorrhiza Bunge J. Proteome Res. 2010, 9, 1565-1578
34. 1H NMR spectroscopic metabonomic studies Anal. Chem. 2005, 77, 517-526
35. Eriksson, L.; Trygg, J.; Wold, S. CV-ANOVA for significance testing of PLS and OPLS® models J. Chemom. 2008, 22, 594-600
36. 13C NMR spectroscopy of human blood plasma Anal. Chem. 1995, 67, 793-811
37. Tang, H.; Wang, Y.; Nicholson, J. K.; Lindon, J. C. Use of relaxation-edited one-dimensional and two dimensional nuclear magnetic resonance spectroscopy to improve detection of small metabolites in blood plasma Anal. Biochem. 2004, 325, 260-272
38. Warburg, O.; Wind, F.; Negelein, E. The Metabolism of Tumors in the Body J. Gen. Physiol. 1927, 8, 519-530
39. Warburg, O. On the origin of cancer cells Science 1956, 123, 309-314
40. Garber, K. Energy boost: the Warburg effect returns in a new theory of cancer J. Natl. Cancer Inst. 2004, 96, 1805-1806
41. Vander Heiden, M. G.; Cantley, L. C.; Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 2009, 324, 1029-1033
42. Bayley, J. P.; Devilee, P. The Warburg effect in 2012 Curr. Opin. Oncol. 2012, 24, 62-67
43. Hanahan, D.; Weinberg, R. A. Hallmarks of cancer: the next generation Cell 2011, 144, 646-674
44. Parker, C. E. Diseases of phenylalanine metabolism West. J. Med. 1979, 131, 285-297
45. Soeters, P. B.; de Blaauw, I.; van Acker, B. A.; von Meyenfeldt, M. F.; Deutz, N. E. In vivo inter-organ protein metabolism of the splanchnic region and muscle during trauma, cancer and enteral nutrition Baillieres Clin. Endocrinol. Metab. 1997, 11, 659-677
46. Souba, W. W. Glutamine and cancer Ann. Surg. 1993, 218, 715-728
47. Gaurav, K.; Goel, R. K.; Shukla, M.; Pandey, M. Glutamine: A novel approach to chemotherapy-induced toxicity Indian J. Med. Paediatr. Oncol. 2012, 33, 13-20
48. 1H NMR metabonomic analysis in renal cell carcinoma: a possible diagnostic tool J. Proteome Res. 2010, 9, 4038-4044
49. Lai, H. S.; Lee, J. C.; Lee, P. H.; Wang, S. T.; Chen, W. J. Plasma free amino acid profile in cancer patients Semin. Cancer Biol. 2005, 15, 267-276
50. Musolino, C.; Calabro, L.; Bellomo, G.; Cincotta, M.; Di Giacomo, V.; Pezzano, C.; Loteta, B.; Rizzo, V.; Guglielmo, S.; Alonci, A. Lipid profile in hematologic neoplasms Recenti Prog. Med. 2002, 93, 298-301
51. Fiorenza, A. M.; Branchi, A.; Sommariva, D. Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects Int. J. Clin. Lab. Res. 2000, 30, 141-145
52. Halton, J. M.; Nazir, D. J.; McQueen, M. J.; Barr, R. D. Blood lipid profiles in children with acute lymphoblastic leukemia Cancer 1998, 83, 379-384
53. Podo, F. Tumour phospholipid metabolism NMR Biomed. 1999, 12, 413-439
54. Franks, S. E.; Smith, M. R.; Arias-Mendoza, F.; Shaller, C.; Padavic-Shaller, K.; Kappler, F.; Zhang, Y.; Negendank, W. G.; Brown, T. R. Phosphomonoester concentrations differ between chronic lymphocytic leukemia cells and normal human lymphocytes Leuk. Res. 2002, 26, 919-926
55. Glunde, K.; Serkova, N. J. Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism Pharmacogenomics 2006, 7, 1109-1123
56. 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis Cancer Sci. 2009, 100, 782-785
57. Cano, K. E.; Li, L.; Bhatia, S.; Bhatia, R.; Forman, S. J.; Chen, Y. NMR-based metabolomic analysis of the molecular pathogenesis of therapy-related myelodysplasia/acute myeloid leukemia J. Proteome Res. 2011, 10, 2873-2881
58. Munoz-Pinedo, C.; El Mjiyad, N.; Ricci, J. E. Cancer metabolism: current perspectives and future directions Cell Death Dis. 2012, 3, e248
59. Evans, J. M.; Donnelly, L. A.; Emslie-Smith, A. M.; Alessi, D. R.; Morris, A. D. Metformin and reduced risk of cancer in diabetic patients Br. Med. J. 2005, 330, 1304-1305
60. Viollet, B.; Guigas, B.; Sanz Garcia, N.; Leclerc, J.; Foretz, M.; Andreelli, F. Cellular and molecular mechanisms of metformin: an overview Clin. Sci. (London) 2012, 122, 253-270